Task: Answer the multiple-choice question.
Question: Which drug exhibits a 6.753% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) CC(C)N(C)C(=O)CCc1nnc(CCc2c[nH]c3ccccc23)o1
b.) O=C(O)CN1CCN(Cc2ccccc2Cl)C1=O
c.) O=C(NCc1ccccc1)C(c1cccs1)N(C(=O)c1csnn1)C1CC1
Answer: a. CC(C)N(C)C(=O)CCc1nnc(CCc2c[nH]c3ccccc23)o1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)N(C)C(=O)CCc1nnc(CCc2c[nH]c3ccccc23)o1
CC(C)N(C)C(=O)CCc1nnc(CCc2c[nH]c3ccccc23)o1
3-[5-[2-(1H-indol-3-yl)ethyl]-1,3,4-oxadiazol-2-yl]-N-methyl-N-propan-2-ylpropanamide